D. Rogers

发表

Acute splenic sequestration and hypersplenism in the first five years in homozygous sickle cell disease.

M. Stevens, G. Serjeant, J. Topley, 1981, Archives of disease in childhood.

Monoclonal antibodies for detecting bone marrow invasion by neuroblastoma.

J. Treleaven, D. Rogers, J. Pritchard, 1989, Journal of clinical pathology.

Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995–1996

B. Plikaytis, D. Vugia, A. Reingold, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London.

F. Kirkham, O. Wilkey, S. Chakravorty, 2007, Haematologica.

The effect of intralesional interferon gamma on basal cell carcinomas.

D. Whiting, D. Rogers, L. Edwards, 1990, Journal of the American Academy of Dermatology.

Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26.

D. Rogers, J. Pritchard, E. Shafford, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

9 Infections in the compromised child

C. Viscoli, E. Castagnola, D. Rogers, 1991 .

Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide.

J. Bergh, M. Piccart, R. Coombes, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

‘High dose’ cisplatinum: a phase II study

B. Bernardi, G. Dini, E. Lanino, 1987 .

High-dose cisplatin and etoposide in advanced malignancies of childhood.

G. Dini, G. Perin, B. De Bernardi, 1987, Pediatric hematology and oncology.

Resistant and relapsing neuroblastoma: improved response rate with a new multiagent regimen (OC-HDP) including high-dose cisplatinum.

P. Cornaglia-Ferraris, G. Dini, E. Lanino, 1987, Medical and pediatric oncology.

Early deaths in Jamaican children with sickle cell disease.

G. Serjeant, D. Rogers, B. Sparke, 1978, British medical journal.

Role of Broviac catheters in infections in children with cancer.

B. Bernardi, G. Dini, L. Boni, 1988, The Pediatric infectious disease journal.

Infections in the compromised child.

C. Viscoli, E. Castagnola, D. Rogers, 1991, Bailliere's clinical haematology.

ALLOGENEIC BONE-MARROW TRANSPLANTATION IN INFANTILE MALIGNANT OSTEOPETROSIS

A. Casey, R. Levinsky, C. Sieff, 1983, The Lancet.

Disseminated neuroblastoma (stage IV and IV‐S) in the first year of life. Outcome related to age and stage

P. Bruzzi, E. Lanino, L. Boni, 1992, Cancer.

Myeloablative therapy and unpurged autologous bone marrow transplantation for poor-prognosis neuroblastoma: report of 34 cases.

G. Dini, E. Lanino, C. Viscoli, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Localized neuroblastoma. Surgical and pathologic staging

M. Carli, G. Paolucci, E. Madon, 1987, Cancer.

Outcome following late marrow relapse in childhood acute lymphoblastic leukemia.

D. Rogers, A. Leiper, J. Chessells, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.

P. Bruzzi, G. Tonini, B. Bernardi, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Early rise in the "pitted" red cell count as a guide to susceptibility to infection in childhood sickle cell anaemia.

G. Serjeant, B. Serjeant, D. Rogers, 1982, Archives of disease in childhood.

EARLY SPLENOMEGALY IN HOMOZYGOUS SICKLE-CELL DISEASE: AN INDICATOR OF SUSCEPTIBILITY TO INFECTION

G. Serjeant, D. Rogers, S. Vaidya, 1978, The Lancet.

BONE-MARROW TRANSPLANTATION HAS A LIMITED ROLE IN PROLONGING SECOND MARROW REMISSION IN CHILDHOOD LYMPHOBLASTIC LEUKAEMIA

R. Levinsky, D. Rogers, H. Blacklock, 1986, The Lancet.

Resection of primary tumor at diagnosis in stage IV-S neuroblastoma: does it affect the clinical course?

P. Bruzzi, B. De Bernardi, F. Cozzi, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pharmacokinetics of melphalan in children following high-dose intravenous injection

D. Rogers, H. Rogers, R. Ahmad, 1983, Cancer Chemotherapy and Pharmacology.

Long-term survival after advanced neuroblastoma.

L. Spitz, D. Rogers, J. Pritchard, 1987, The New England journal of medicine.

Localized but unresectable neuroblastoma: treatment and outcome of 145 cases. Italian Cooperative Group for Neuroblastoma.

A. Donfrancesco, L. Boni, M. Carli, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Surgical and Pathologic Staging

B. Bernardi, G. Paolucci, E. Madon, 1987 .